Autologous blood cell transplantation in B-CLL: Response to chemotherapy prior to mobilization predicts the stem cell yield

被引:30
作者
Itala, M [1 ]
Pelliniemi, TT [1 ]
Rajamaki, A [1 ]
Remes, K [1 ]
机构
[1] UNIV TURKU,CENT HOSP,DEPT LAB HEMATOL,FIN-20520 TURKU,FINLAND
关键词
CLL; autologous stem cell transplantation;
D O I
10.1038/sj.bmt.1700730
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Successful stem cell mobilization and collection is possible in B-CLL after a favorable response to preceding chemotherapy, and also after treatment with the new nucleoside analogues fludarabine and cladribine, A poor response, on the other hand, seemed to predict a mobilization failure, CD34(+) cell selection resulted in a 2- to 3-log reduction of the CLL cells in the harvests, Engraftment with both unselected and selected progenitor cells was rapid, and need for hospitalization was short. High-dose therapy,vith stem cell rescue appears to be capable of inducing CRs of high quality, but so far the follow-up is too short to define whether this will be translated into prolonged disease-free survival.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 14 条
[1]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[2]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[3]  
2-V
[4]   GUIDELINES FOR CLINICAL PROTOCOLS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - RECOMMENDATIONS OF THE NATIONAL-CANCER-INSTITUTE-SPONSORED-WORKING-GROUP [J].
CHESON, BD ;
BENNETT, JM ;
RAI, KR ;
GREVER, MR ;
KAY, NE ;
SCHIFFER, CA ;
OKEN, MM ;
KEATING, MJ ;
BOLDT, DH ;
KEMPIN, SJ ;
FOON, KA .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (03) :152-163
[5]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[6]  
DREGER P, 1996, ANN ONCOL S3, V7, P17
[7]   High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission [J].
Freedman, AS ;
Gribben, JG ;
Neuberg, D ;
Mauch, P ;
Soiffer, RJ ;
Anderson, KC ;
Pandite, L ;
Robertson, MJ ;
Kroon, M ;
Ritz, J ;
Nadler, LM .
BLOOD, 1996, 88 (07) :2780-2786
[8]  
GAHN B, 1996, ANN ONCOL S3, V7, P17
[9]  
Johnsen H E, 1995, J Hematother, V4, P21, DOI 10.1089/scd.1.1995.4.21
[10]   AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS [J].
KHOURI, IF ;
KEATING, MJ ;
VRIESENDORP, HM ;
READING, CL ;
PRZEPIORKA, D ;
HUH, YO ;
ANDERSSON, BS ;
VANBESIEN, KW ;
MEHRA, RC ;
GIRALT, SA ;
IPPOLITI, C ;
MARSHALL, M ;
THOMAS, MW ;
OBRIEN, S ;
ROBERTSON, LE ;
DEISSEROTH, AB ;
CHAMPLIN, RE .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :748-758